title: Aberrant expression of cell cycle regulatory genes predicts overall and disease free survival in malignant pleural mesothelioma patients.
abstract: BACKGROUND
  Malignant pleural mesothelioma (MPM) is a highly aggressive disease with a generally poor prognosis. Since escape from cell cycle checkpoint control is common in several solid tumors, the present study was performed to evaluate the role of some cell cycle regulatory genes in the development and progression of MPM.
  
  
  METHODS
  Aberrant expression of p14(ARF), p16(INK4A), p21(waf), p27(KIP), p53, mdm2 and Rb was assessed in 55 MPM cases from Egypt using immunohistochemistry and PCR techniques. Results were correlated with clinico-pathological prognostic factors, overall and disease free survival (OS&DFS).
  
  
  RESULTS
  Altered expression of p14(ARF), p16(INK4A), p21(waf), p27(KIP1), Rb, p53 and mdm2 proteins was detected in 50.9%, 54.5%, 53.3%, 61.8%, 53.3%, 58.2%, and 50.8% of cases, respectively. SV40 infection significantly correlated with p14(ARF), 16(INK4A), p27(kip1) and Rb aberrations (p=0.014, p=0.02, p=0.01, p=-0.01). Asbestos exposure significantly correlated with p53, p21(waf) and mdm2 aberrations (p=0.001, p=0.03, p=0.02). On multivariate analysis PS ≥ 2, p27(KIP1) and Rb aberrations were independent prognostic factors for OS (p=0.016, p=0.011, p=0.003) whereas on tumor recurrence, p27(KIP1) and Rb aberrations were independent prognostic factors for DFS (p=0.002, p=0.03, p=0.01).
  
  
  CONCLUSIONS
  MPM is a complex disease characterized by multiple genetic aberrations; some of them involve cell cycle regulatory genes. p14(ARF), p16(INK4A), Rb and p27(KIP1) seem to be involved in SV40-associated MPM whereas mdm2, p53 and p21(WAF) are related to asbestos exposure. In addition to recurrence and PS, only p27(KIP1)and Rb could be used as molecular prognostic markers in MPM.
authors.affiliation: Pathology, Department, National Cancer Institute, Cairo University, Egypt. chaya2000@hotmail.com
authors.forename: Abeer A
authors.initials: AA
authors.lastname: Bahnassy
authors.forename: Abdel-Rahman N
authors.initials: AR
authors.lastname: Zekri
authors.forename: Amany A
authors.initials: AA
authors.lastname: Abou-Bakr
authors.forename: Mervat M
authors.initials: MM
authors.lastname: El-Deftar
authors.forename: Ahmad
authors.initials: A
authors.lastname: El-Bastawisy
authors.forename: Mona A
authors.initials: MA
authors.lastname: Sakr
authors.forename: Ghada M
authors.initials: GM
authors.lastname: El-Sherif
authors.forename: Rabab M
authors.initials: RM
authors.lastname: Gaafar
mesh_terms: D000328:Adult; D000368:Aged; D002453:Cell Cycle / Q000235:genetics*; D018797:Cell Cycle Proteins / Q000235:genetics*; D018572:Disease-Free Survival; D004534:Egypt; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008654:Mesothelioma / Q000235:genetics / Q000401:mortality* / Q000473:pathology; D008875:Middle Aged; D010997:Pleural Neoplasms / Q000235:genetics / Q000401:mortality* / Q000473:pathology; D055815:Young Adult
chemical_list: D018797:Cell Cycle Proteins